InvestorsHub Logo

rafunrafun

09/05/19 12:09 PM

#212777 RE: Atom0aks #212774

A -

here is a similar controversy regarding statins


What controversy? The only 'controversy' that I am aware of is that I think that hundreds of deaths and thousands of events in 3 months is a lot, while you think that it's "very, very little".

Oh and speaking of statins, NNT for Vascepa is 21, while:

Atorvastatin (Lipitor®) is 45

Evolocumab(Repatha®) is 67


Know who has the identical modus operandi to yours? Yep, you guessed it.

massulo52

09/05/19 12:55 PM

#212785 RE: Atom0aks #212774

So have you posted this on every Biotech pages to avail this information about RRR vs ARR also or just Amarin's pages?